Heart Institute installs advanced imaging systems for preclinical research
The USF Health Heart Institute has installed new variable 7T-3T MR/PET and PET-CT integrated imaging systems – establishing the first comprehensive preclinical imaging suite at the USF Health […]
Inhibiting thrombin protects against dangerous infant digestive disease
A USF Health-Johns Hopkins Medicine team shows that nanoparticles targeting the blood-clotting protein reduces necrotizing enterocolitis-like injury in neonatal mice TAMPA, Fla. (May 4, 2020) — Necrotizing enterocolitis […]
Leading expert on role of immune cells in atherosclerosis featured at Heart Institute scientific colloquium
A leading expert on the role of monocytes and macrophages (types of immune cells) in atherosclerosis and other chronic inflammatory conditions delivered the keynote address Nov. 7 at […]
Silencing RNA nanotherapy shows promise against pancreatic cancer
A Washington University-USF Health preclinical study finds that the novel nanoparticle delivers gene-level treatment to suppress KRAS-driven cancer without adverse effects Despite advances in cancer survival, more than […]
USF Health research institutes rank in State University System’s Top 10
Two USF Health Morsani College of Medicine research-focused institutes rank among the Top 10 Institutes and Centers within Florida’s State University System (SUS). The ranking was derived […]
MCOM researchers part of study using new mouse model linking transfusions to dangerous digestive disease in infants
USF Health Heart Institute scientists developed nanoparticles deployed to suppress inflammation in the bowels of anemic infant mice, preventing transfusion-associated intestinal injury Physicians have long suspected that red […]
Nano-delivered therapy inhibits spread of ovarian, uterine cancer cells
The peptide-siRNA nanoparticle technology applied in the preclinical study was developed by USF Health Heart Institute researchers Advanced ovarian and uterine cancers are deadly diseases. Ovarian cancers, in […]
Nanoparticle therapy blocks tumor angiogenesis without cardiac side effects
Preclinical cancer study has implications for inhibiting atherosclerotic plaque growth The formation of new blood vessels, known as angiogenesis, is essential for embryonic tissue development, wound healing and […]
USF Health Heart Institute director named to AIMBE College of Fellows
March 25, 2019 — USF Health Heart Institute Director Samuel Wickline, MD, a pioneer in nanotechnology targeting heart disease and other disorders, has been inducted into the American […]
Heart Institute hosts first research symposium
The USF Health Heart Institute recently hosted its inaugural scientific conference, marking another milestone in the young Institute’s short history and setting a standard for future collaborative work […]